The influence of infusion rate on the induction doseresponse relation has not been investigated over a wide range of infusion rates. In this study, the authors defined the effect of different propofol infusion rates on the times and doses necessary to reach clinical induction of anesthesia.
THE importance of injecting propofol slowly to avoid an overdose and to minimize cardiorespiratory depression is widely accepted.'-3 However, previous reports show substantial variability in the relations among infusion rate, induction dose, and induction time. Many researchers have reported that a slower rate of propofol administration for induction of anesthesia results in smaller dose requirements and that the time necessary for induction is significantly longer at slower infusion rates3,* This seems to be a straightforward simple correlation; however, it is not so simple. The relations among rate of drug administration, induction time, and dose requirement pose interesting questions that merit further consideration because of the variety of possible relations among infusion rate, induction time, and These relations have not been investigated systematically using a wide range of infusion rates.
In traditional pharmacokinetic models, an intravenously administered drug is assumed to be injected into the central compartment rather than into a stream of flowing blood. This becomes a major limitation of assumptions about the physiologic effect of a drug, especially at a high infusion rate. With administering a drug that is carried through the circulatory system to the site of drug effect, a certain amount of drug is contained in the circulation from the site of administration to the central compartment. The lag time from infusion site to central compartment (lag timecircularion) and the amount of this drug in circulation (residual dosecirculation), which UAZAMA ET AL.
is correlated with lag timecirculation, are dependent on the infusion rate and dilution of the drug.
In addition to the lag timecirculation, there is another lag time from the central compartment to effect site that is defined as the time constant of the effect-site rate constant (ke0) and the dose in the central compartment at loss of consciousness (residual dose,,,,,,)
is dependent on the infusion rate of the drug.
If propofol administration is titrated with a high continuous propofol infusion rate, the anesthesiologist may administer a larger dose than is necessary to achieve loss of consciousness, and such large doses may cause a decrease in systemic arterial blood pressure. However, the relation between rate of infusion and induction dose described by previous reports is incomplete because of the small range of infusion rates used and the lack of consideration of all residual doses.
The current study was designed (1) to determine the relation between infusion rate, induction time, and induction dose using a wide range of propofol infusion rates from 10-300 mg kg-' * h-'; (2) to determine whether the use of diluted propofol lessens the residual dosecircu,ation; (3) to compare our results with a previously published pharmacokinetic and pharmacodynamic model; and (4) to investigate the hemodynamic responses to these various infusion states.
Materials and Methods
Written, informed consent was obtained from each patient after explanation of the study, which was approved by the District Ethics Committee of the Hamamatsu University Hospital. The subjects selected for this study were unpremedicated patients classified as American Society of Anesthesiologists physical status I or 11, aged 25-55 yr, who were scheduled for elective surgery. Exclusion criteria included a history of cardiac, pulmonary, liver, or renal disease and the presence of significant obesity (body mass index 3 26). At arrival of the unpremedicated patient in the operating room, an 18-gauge cannula was inserted into a large antecubital vein during local anesthesia. Lactated Ringer's solution was infused ( 3 mlkg-'h-') until the start of propofol infusion for anesthesia induction. During baseline recording, oxygen was administered with a face mask. Anesthesia was induced using a previously assigned propofol infusion rate until loss of verbal contact with the patient. The patients were asked to open their eyes or to otherwise indicate that they were still conscious. If no response to this stimulus occurred, the patients were stimulated by gently rubbing and tapping their shoulders. Loss of consciousness was defined as no response to these stimuli. In all patients, responses to stimuli were assessed every 20, 10, 5, and 2.5 s at the infusion rates from 10-15, from 20-30, from 40 -100, and from 200 -300 mgkg-'h-', respectively, by the same attending anesthesiologist and the same assistant resident anesthesiologist, who were both blind to the assigned infusion rate or infused propofol concentration. Both anesthesiologists were completely familiar with the strict definition of response. The induction time was defined as the time from the start of propofol infusion to loss of consciousness, and the induction dose was defined as the amount of propofol administered before loss of consciousness.
Induction with Undiluted Propofol (10 mg/ml; Group A)
After 5 min preoxygenation, propofol was administered by infusion pumps through a three-way tap placed directly into the venous cannula. During propofol infusion, lactated Ringer's solution was discontinued. Ninety patients were assigned randomly to nine study groups (10 patients/group) to receive infusion of propofol at one of the following rates: 10, 15, 20, 30, 40, 60, 100, 200, or 300 mg * kg-lh-' (table 1) . Infusion was controlled by conventional syringe infusion pump (Graseby 3500; Graseby Medical, Colonial Way, Watford, Herts, UK), with rates of 60 mgkg-'h-l or more necessitating several infusion pumps at once because of the infusion-rate limitation of a single pump.
Induction with Undiluted Propofol Accompanied by Crystalloid Solution Infusion in the Opposite Hand (Group B)
Ninety patients were assigned randomly to one of nine study groups of different undiluted propofol infusion rates: 10, 15, 20, 30, 40, 60, 100, 200, or 300 mg-kg-' * h-' . Propofol administration followed the same procedures as described for group A. A second intravenous infusion catheter was placed in the opposite hand for lactated Ringer's solution infusion at rates of 20, 30, 40, 60, 80, 120, 200,400, or 300 mlkg-'h-' at the same time as each respective propofol infusion (table 2) . For infusion rates less than 40 mlkg-' * h-', lactated Ringer's solution was infused with Graseby syringe infusion pumps. At the other infusion rates, it was infused manually, and the infusion volume was checked every second. After loss of consciousness, the infusion rate was adjusted again to 3 ml * kg-'h-'.
Induction with Diluted Propofol (Group C)
Seventy patients were assigned randomly to one of seven groups of different diluted propofol infusion rates: 10, 15, 30,60, 100, 200, or 300 mgkg-' * h-' (table 3) .
Diluted propofol at 0.5 mg/ml was used for induction except for the infusion rate of 300 mg . kg-' * h-', for which diluted propofol at 1.0 mg/ml was used because of the technical limitations of infusion speed. Propofol diluted 20 times with lactated Ringer's solution was prepared just before anesthesia induction. After 5 min preoxygenation, propofol was infused at the assigned rates through the three-way tap placed directly into the venous cannula. For the infusion rates less than 15 mg kg-' * h-', diluted propofol was infused with Graseby syringe infusion pumps. For the other infusion rates, diluted propofol was infused manually as described previously.
Pain or discomfort at the site of injection during or after propofol administration was recorded and graded by the attending anesthesiologist as mild, moderate, or severe, according to patient facial expressions, arm movements, or reports of pain. Incidents of spontaneous movement and vocalization during induction were re-corded. End-tidal carbon dioxide measurement was used to detect any incidence of apnea lasting more than 30 s.
Spontaneous respirations were assisted manually if necessary. Heart rate, electrocardiographic data, end-tidal carbon dioxide, oxyhemoglobin saturation, and noninvasive blood pressure (1-min interval; CBM7000; Nihon Colin, Komaki, Japan) were monitored continuously throughout this study.
Immediately , after loss of consciousness, infusion of undiluted propofol (10 mg/ml) was commenced at 4 mg * kg-' * h-', and hemodynamic change was recorded for 20 min. Then, intubation was facilitated by fentanyl, 0.1 or 0.2 mg, and vecuronium, 0.1 mg/kg. Cardiovascular recordings were made for 5 min at the commencement of monitoring as a baseline measurement. The minimum value of systolic blood pressure (SBP) during the 20 min after loss of consciousness and the heart rate at the minimum SBP were designated as the postinduction values. If hypotension (< 75 mmHg, or > 40% SBP decrease) persisted for 2 or 3 min, patient blood pressure was restored by ephedrine.
Although propofol was infused as a function of real body weight, the relation among induction dose, induction time, SBP decrease, propofol plasma concentration, and propofol infusion rate was investigated as a function Induction dose (mg) 9 2 + 6 9 0 2 1 4 7 7 2 1 1 8 7 2 7 9 6 2 1 8 1 0 6 2 1 5 *
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Data are mean t SD. of lean body mass (LBM). LBM was determined from height (cm) and weight (kg) using gender-specific formulas.'
At a 24-h postoperative examination, each patient was asked whether he or she recalled any event occurring after loss of consciousness. At that time, the injection site was evaluated for possible phlebitis, irritation, or thrombosis.
A femoral arterial blood sample (3 rnl) was taken from each patient for analysis of plasma propofol concentration at unresponsiveness to verbal and tactile stimuli. The blood samples were immediately placed on ice, after which the plasma was separated and frozen at -70°C until it was assayed. Plasma concentrations of propofol were determined using high-performance liquid chromatography with fluorescence detection at 310 nm after excitation at 276 nm (CTO-lOA, RF550, and C-R7A; Shimadsu, Kyoto, Japan). The lower limit of detection was 32 ng/ml. 
Simulations of Infusion Rate versus Propofol Induction Dose and Induction Time
To simulate the blood concentration histories of zeroorder infusions/LBM at rates from 10-450 mg * kg-' * h-', previous pharmacokinetic parameters for a 42-yrold, 57-kg, 160-cm man reported by Schnider et d9 were used. The k,, for propofol equilibration of 0.456/minwas used to link the effect with the central compartment propofol concentrations. Effect-site concentration at loss of consciousness (Ce,,,) was adjusted to 3.49 Fg/ml as the simulated induction dose derived from the findings of Schnider et d9 findings became equal to our mean induction dose of group A,, (table 1). The infusion rate used in our group A,, was the same as that in the Schnider et u Z .~ study.9 The pharmacokinetic parameters of Schnider et aL9 were derived from the data of an extremely low infusion rate, from 1.5-12 mg * kg-'h-at which lag timecirculation and residual dosecirculation were negligible because lag timecirculation is extremely small compared with induction time. Induction dose and time to reach the normalized effect-site concentration of loss of consciousness (3.49 Fg/mlj were calculated at constant infusion rates/LBM from 10-450 mg * kg-' * 
Results
Among the 250 patients, 10 in each infusion subgroup of groups A, B, and C , there were no statistically significant differences between the groups in gender ratio, age, height, weight, or LBM (tables 1-3). In all groups, anesthesia could be induced within 15 min with the predetermined propofol infusion rates, and no patients needed an additional propofol bolus infusion because of unsuccessful induction. The quality of anesthesia induction with propofol in all groups is summarized in table 4.
Apnea occurred far more often at the faster administration rates than at the slower ones.
There was no excitatory movement. Injection pain was 5-30% in each group. In the diluted propofol group, higher propofol injection rates tended to provoke increases in the intensity of pain. Vocalization, meaning spontaneous speech, was significantly more frequent at lower infusion rates than at higher ones in groups receiving undiluted and diluted propofol both. At 24-h postoperative examinations, no patients showed complications such as persistent pain, redness, swelling, thrombophlebitis, and memory of awareness during induction. Three patients, two from group A and one from group B, were administered ephedrine because of hypotension. We recorded the lowest SBP before injection of ephedrine in these patients. In three patients from group A, blood samples could not be obtained within 10 s after loss of consciousness.
Various rates of crystalloid solution infusion in the opposite hand had no significant effect on induction Table 4 time, induction dose, plasma propofol concentration at loss of consciousness, or percentage decrease in SBP (tables 1 and 3). The induction time showed an initial steep decrease; however, it became fairly flat at infusion rates greater than 100 mg * kg-' h-' ( fig. 1) . At all infusion rates, observed induction time necessary with undiluted propofol was an average of 21.9 s greater than that necessary with diluted propofol. In undiluted propofol, simulated induction time calculated with previously reported pharmacokinetic and pharmacodynamic parame-ter~'~" was underestimated compared with the observed induction time ( fig. 1 ). The observed mean induction times at infusion rates greater than 100 mg * kg-' h-' clearly were relevant to the simulated induction time with a 20-s lag timecirculation ( fig. 1) . In diluted propofol, the observed times at rates more than 100 mgkg-'h-' were relevant to the predicted line with a 0-s lag timecirculation ( fig. 1 ).
. Quality of Induction of Anesthesia
The relation between induction dose and infusion rate was not simple. In the. simulation this relation clearly was concave when plotted ( fig. 2 ). However, plotting the observed relation between induction dose and infusion rate did not produce a clear concave line. At infusion rates less than 80 mg kg-' * h-' for undiluted propofol, the actual observed dose for induction was similar to the predicted dose combined with an additional residual dosecirculation that corresponds with a 60-s lag timecirculation. At the infusion rates greater than 80 mg * kg-' * h-', the observed dose was similar to the predicted dose combined with an additional residual dosecirculation that corresponds with 20 s of lag timecirculation ( fig. 2 ). For diluted propofol, the observed dose was similar to the predicted dose combined with an additional residual dosecirculation corresponding to 40 s of lag timecirculation at infusion rates less than 80 mgkg-' - h-'. At infusion rates greater than 80 mg * kg-' h-', the observed dose was similar to the predicted dose ( fig. 2) . In all infusion rates, the induction doses with undiluted propofol were greater than those with diluted propofol, and the difference corresponded to the residual dosecirculation for approximately 20-30 s at each infusion rate
The plasma propofol concentration at loss of consciousness increased with propofol infusion rate in all groups ( fig. 3; tables 1-3) . Although at the infusion rates less than 40 mg * kg-'hpl the plasma concentrations for both undiluted and diluted propofol were similar, the concentrations for undiluted propofol were significantly higher than those for diluted propofol at higher infusion rates.
Systolic blood pressure did not change significantly at infusion rates less than approximately 80 mg kg-' * h-I of undiluted and diluted propofol. At infusion rates greater than 80 mg * kg-' * h-', SBP decreased significantly in the undiluted propofol groups ( fig. 4; tables 1 and 2). In the diluted propofol groups, decreases in SBP were less marked, even at higher infusion rates ( fig. 4;  table 3 ).
( fig. 2 ).
Discussion
We evaluated the induction state from extremely low rates to extremely high rates of undiluted or diluted propofol infusion, which encompassed a much greater range than reported previously. during the extreme condition of a 30-fold range of infusion rates. However, there were systematic differences between our observed induction dose and the dose predicted by this model even if we normalized this model to our data. Previous descriptions of the relation between rate of infusion and induction dose have been incomplete because not all necessary components were evaluated. 3, 4 The relation between induction dose and infusion rate can be explained with four primary factors.
First is the amount of propofol removed from the central compartment, with clearance that depends on the concentration in the central compartment. The clearance from the central compartment by metabolism and distribution is approximately 4.0 -5.5
Second is the residual dosecentral. Although the plasma concentration peaks almost instantly, additional time is necessary for the drug concentration in the brain to rise and induce unconsciousness. The time lag is defined as time constant of k,, of the effect site. Third is residual dosecirculation that is correlated with lag timecirculation. This has not been investigated precisely. Fourth is rapid residual dosecirculation for a 20-s lag time was necessary. For diluted propofol, 40 s for less than 80 mg * kg-' * h-' and 0 s for more than 80 mg kg-' h-' of additional residual dosecirculation were necessary ( fig. 2) .
At all infusion rates, the difference in residual dosecirculation between undiluted and diluted propofol can be explained by the difference of lag timecirculation for approximately 20 s provoked by a 20-fold dilution of propofol. However, the downward change of induction dose at infusion rates greater than 80 mgkg-' * h-' in undiluted and diluted propofol cannot be explained with residual dosecirculation and has not been reported previously. In addition to the residual doses, rapid circulation resulting from incomplete mixing of the central compartment helps to explain the downward change at higher infusion rates. The involvement of rapid circulation resulting from incomplete mixing has been ignored in conventional compartment models. However, the mechanisms of this process are well-iinderstood and can be described by indicator dilution principles. Bolus infusion of indocya-nine green can be used to define intravascular mixing transients. After central venous administration, there is a finite delay before the first indocyanine green appears at a sampling site.I6 Recirculation returns the drug through the central blood circuit to generate an oscillatory peak, which becomes damped on subsequent recirculations. l7 Roerig et al. l8 demonstrated in humans that indocyanine green concentration in a radial artery started to increase at approximately 15 s and peaked between 19 and 24 s after a bolus injection from a central venous catheter, with a second peak at 40 -42 s representing the second circulation. Vecuronium onset time to 95% twitch depression was 21 s less during administration in the right atrium than in a peripheral vein19; that is, the lag time between peripheral vein and radial artery is from 36 to 45 s. Our additional evidence that rapid circulation begins to influence the induction with continuous infusion at infusion rates more than 60 mg kg-' * h-', and that it becomes a main factor for induction at infusion rates more than 150 mgkg-'h-l.
In continuous infusion, initially, arterial propofol concentration increases more rapidly in a condition of incomplete mixing than in one of immediate complete mixing, although both conditions reach the same concentration progressively. The initial accelerative increase of propofol concentration causes a decrease of induction dose at high infusion rates. Our downward variation of residual dosecirculation at infusion rates more than 80 mg * kg-'h-' may have resulted from the decrease of induction dose provoked by the incomplete mixing.
For various lag timecirculation values, simulation of infusion rate versus propofol concentration of central compartment at loss of consciousness is shown in figure 8 . At lower infusion rates, predicted concentrations with measured induction doses for undiluted and diluted propofol were similar, and they were consistent with our ob- rates greater than 80 mg kg-' h-', our observed plasma propofol concentrations were less than half the predicted ones ( figs. 3 and 8) . The predicted central concentration was obtained by measuring an induction dose that included residual dosecirculation. Blood samples were taken within 10 s after loss of consciousness, when residual dosecirculation had not yet circulated to the artery side completely, which explains the discrepancy between predicted and measured propofol concentrations.
Upton20,21 demonstrated that the time course of arterial concentration of drug administered in a bolus injection depends on dose rate, cardiac output, and magnitude of lung extraction. Hemodynamic depression occurs after loss of consciousness because t,,,k,, (tl,2ke0 = ln2/ke,) of SBP is 2.5 times more than that of the electroencephalographic bispectral index.22 SBP decreased significantly more than 30% from preinduction values at high infusion rates of undiluted propofol in our study ( fig. 4 ; tables 1-3). Cardiac output might decrease and influence induction dose; however, the maximal SBP decrease occurred after loss of consciousness. This suggests that cardiac output did not change significantly before loss of consciousness, and that it did not affect the induction dose and time in our study.
The crystalloid solution used in the dilution of propofol might change cardiac output. However, in our study, the various crystalloid infusion rates of the opposite hand in group B had no significant effects on induction time, induction dose, plasma propofol concentration at loss of consciousness, or percentage decrease in SBP (tables 1 and 3). The maximum crystalloid infusion rate was approximately 0.4 l/min. We suppose this amount of change in cardiac output would not influence the induction time, dose, or SBP depression.
For steady state lung extraction (Elung [%I) of propofol against pulmonary artery concentration, Upton and Lud-brook23 reported that the relation between the inverse of extraction (l/Elung) and the afferent pulmonary artery concentration (C,,) could be described by the following equation:
1/ElUng = 0.007 C,, + 0.013 According to this equation, Elung values at 6.0 and 22 pg/ml of pulmonary artery concentrations are 18.2 and 6.0%. If the pulmonary artery concentration is close to the arterial concentration, infusion rates in these pulmonary artery concentrations would be approximately 26 and 385 mg kg-'h-', respectively, in our study (tables 1-3). Consequently, doses extracted with the lung are 0.36 mg/kg at a 26-mg * kg-'h-' infusion rate and 0.3 mg/kg at a 385-mgkg-' * h-' infusion rate. This suggests that the dose extracted in the lung is almost constant with low and high infusion rates both, although the lung extraction might affect the induction dose.
In summary, we investigated propofol induction doses using a wide range of infusion rates with undiluted and diluted propofol. In addition to the residual dosecentral and lag time between the central compartment and effect site with increasing infusion rates, induction dose and time increased as much as residual dosecirculation and lag timecirculation. However, at infusion rates greater than 80 mgkg-'h-', rapid circulation resulting from incomplete mixing in the central compartment decreased induction dose and time. Overdosing related to residual dosecirculation could be alleviated with the use of diluted propofol.
